Morten Persson
Rigshospitalet(DK)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Peptidase Inhibition and Analysis, Protease and Inhibitor Mechanisms, Medical Imaging Techniques and Applications, Prostate Cancer Treatment and Research
Most-Cited Works
- → First-in-human uPAR PET: Imaging of Cancer Aggressiveness(2015)111 cited
- → Quantitative PET of Human Urokinase-Type Plasminogen Activator Receptor with 64Cu-DOTA-AE105: Implications for Visualizing Cancer Invasion(2012)80 cited
- → Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging(2016)78 cited
- → High tumor uptake of 64Cu: Implications for molecular imaging of tumor characteristics with copper-based PET tracers(2013)77 cited
- → Rational Targeting of the Urokinase Receptor (uPAR): Development of Antagonists and Non-Invasive Imaging Probes(2011)68 cited
- → 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers(2011)61 cited
- → uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model(2016)56 cited
- → Improved PET Imaging of uPAR Expression Using new 64Cu-labeled Cross-Bridged Peptide Ligands: Comparative in vitro and in vivo Studies(2013)50 cited
- → First 18F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts(2013)45 cited
- → Urokinase‐type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications(2013)43 cited